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Abstract
Background: Methamphetamine (METH), an abused illicit drug, disrupts many cellular processes, including energy
metabolism, spermatogenesis, and maintenance of oxidative status. However, many components of the molecular
underpinnings of METH toxicity have yet to be established. Network analyses of integrated proteomic, transcriptomic and
metabolomic data are particularly well suited for identifying cellular responses to toxins, such as METH, which might
otherwise be obscured by the numerous and dynamic changes that are induced.
Methodology/Results: We used network analyses of proteomic and transcriptomic data to evaluate pathways in Drosophila
melanogaster that are affected by acute METH toxicity. METH exposure caused changes in the expression of genes involved
with energy metabolism, suggesting a Warburg-like effect (aerobic glycolysis), which is normally associated with cancerous
cells. Therefore, we tested the hypothesis that carbohydrate metabolism plays an important role in METH toxicity. In
agreement with our hypothesis, we observed that increased dietary sugars partially alleviated the toxic effects of METH. Our
systems analysis also showed that METH impacted genes and proteins known to be associated with muscular homeostasis/
contraction, maintenance of oxidative status, oxidative phosphorylation, spermatogenesis, iron and calcium homeostasis.
Our results also provide numerous candidate genes for the METH-induced dysfunction of spermatogenesis, which have not
been previously characterized at the molecular level.
Conclusion: Our results support our overall hypothesis that METH causes a toxic syndrome that is characterized by the
altered carbohydrate metabolism, dysregulation of calcium and iron homeostasis, increased oxidative stress, and disruption
of mitochondrial functions.
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Introduction
The term ‘‘systems biology’’ refers to the interdisciplinary study
of complex interactions that give rise to the function and
performance of a particular biological system. Currently, tran-
scriptomics, proteomics, and metabolomics are the principal
technology platforms that provide useful data for systems biology
analyses. Data from these various platforms are integrated to
reveal how cellular systems respond to xenobiotics like plant
defense compounds, food ingredients [1,2], pesticides, and drugs,
thereby providing insights into how animals are affected by
xenobiotic challenges and possible ways to alleviate their negative
biological effects.
When used in combination with model organisms, xenobiotic
challenges also provide an opportunity to test analytical approach-
es based on systems biology. For example, METH is a central
nervous system stimulant that is increasingly abused, especially by
teenagers and young adults, and that causes acute and chronic side
effects in multiple organ systems [1,2]. However, most molecular
studies on the impact of METH have focused on brain tissues
[3,4,5], including recent work by Chin et al [6] using combined
proteomic and transcriptomic analyses. However, to our knowl-
edge, there are no systems biology analyses of the impact of
METH on whole organisms. In terms of a model organism,
Drosophila melanogaster has one of the best-defined genomes among
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18215insects [7] and a robust set of available mutants, making it an
excellent system with which to elucidate the mechanisms underlying
the genomic, proteomic, and metabolomic whole-organism re-
sponses to xenobiotics and to obtain follow-up validation through
mutant analysis. Moreover, METH influences evolutionarily
conserved pathways shared by Drosophila and mammals (e.g.,
oxidative phosphorylation). Importantly, xenobiotic perturbations
of conserved molecular pathways have the potential to generate
similar cellular- and organism-level responses across species.
Here we report that the administration of METH to Drosophila
causes a METH-induced cytotoxic syndrome. Consumption of
this drug has been associated with several disorders in humans and
in animal models, including defects in the male reproductive
system, changes in blood sugar levels, induction of oxidative stress,
neurological damage, heart disease, reduction of mitochondrial
energy production, increased lactic acid build up, and apoptosis in
multiple tissues [8,9,10,11,12,13,14,15]. METH syndrome pro-
duces changes in cellular energy metabolism that appear to be
consistent with a Warburg effect, which is characterized by high
levels of glycolysis (followed by lactic acid fermentation) and
decreased oxidative phosphorylation in the mitochondria, even
under aerobic conditions [16,17]. These metabolic changes,
however, could also be consistent with hypoxia. The Warburg
effect has not previously been associated with METH syndrome.
Using a systems biology approach, we present a mechanism-
based model to describe the molecular impacts of METH on
cellular pathways, followed by a mutant analysis of key METH-
responsive genes including those with known and previously
unknown function. We also determined that dietary trehalose
reduced METH toxicity in Drosophila. Trehalose is an antioxidant
and the major blood sugar in insects [18,19]. Combined results
from systems biology and mutant analyses have the potential to
give us an in-depth understanding of the impact of xenobiotics on
cellular and organismal systems.
Results and Discussion
Systems biology elucidates complementary aspects of
the METH syndrome
Gene pathways detected by microarray. To elucidate
potential pathways responsive to METH, we analyzed microarray
data, comparing control and METH-treated Drosophila males
through Gene Ontology (GO) system categorizations (http://
www.geneontology.org) and the Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway analyses (http://www.genome.ad.jp/
kegg/). Genes with a p value smaller than 0.008 and an absolute
fold change greater than 1.5 were considered significant and used
for the analyses. The top eight pathways were (i–v) detoxification/
drug metabolism pathways, (vi) glutathione metabolism, (vii)
glycolysis/gluconeogenesis, and (viii) purine metabolism (Table
S1). In total, we observed 229 differentially transcribed genes and
34 potential pathways, some of which are consistent with METH
syndrome (e.g., energy-associated pathways) and known specific
responses to METH (such as tyrosine metabolism); METH is
known to lead to long-term decreases in the activity of dopamine
transporter and tyrosine hydroxylase [20].
Proteomic analysis. Initially, we identified 226 spectral
peaks that were differentially expressed after METH treatment
(p,0.05 and a fold-change of .2). We were able to identify the
associated peptides for 87 of the original 226 peaks (SpectrumMill
peptide score of .6 and SPI% .60%) (Table S2). Because
multiple peptides were observed for a single protein, only 72
proteins were identified: 33 increased in abundance, 35 decreased,
and 4 proteins (CG4169-PA; ATP synthase- CG11154-PA,
isoform A; enolase CG17654-PE, isoform E; and, MyHC)
(Table S2) had associated peptides that were for unknown
reasons both increased and decreased (they were probably
associated with different isoforms of the same protein). The 72
differentially expressed proteins were then categorized according
to their involvement in 26 pathways, including those relating to
heart and skeletal muscles, oxidative stress, energy, oxidative
phosphorylation, and spermatogenesis. All 26 pathways are known
to be associated with METH responses in mammals (Table S2).
Impact of METH on combined transcriptome and
proteome pathways. The database for annotation,
visualization, and integrated discovery (DAVID) analysis
indicated that a large number of differentially expressed proteins
were involved in glycolysis and oxidative phosphorylation
(Figure 1; Figure S1 and Table S3). Because only one common
protein/gene, glycerol-3-phosphate dehydrogenase (GPDH), was
present in both the proteomic and gene expression data in the
METH-treated flies, we performed multiple pathway analyses in
Figure 1. Changes in abundance of key proteins associated with oxidative phosphorylation. METH exposure results in changes in the
abundance of key proteins in the mitochondrial electron transport chain (ETC), including complexes I, III and V. The direction of the red arrow indicates
specificproteinsthat eitherincreased(up) or decreased(down)in abundance as a resultofMETH exposure. Protein expression datais also givenin Table
S2. The figure for ETC was adapted from http://www.genome.jp/kegg-bin/highlight_pathway?scale=1.0&map=map00190&keyword=oxidative.
doi:10.1371/journal.pone.0018215.g001
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of these analyses revealed somewhat different pathways, all the
pathways identified were consistent with METH syndrome
(Figures S2 & S3). A process network analysis of the proteomic
and microarray data revealed that of the top 10 networks
impacted by METH, 8 were associated with skeletal muscle,
cardiac muscle, cytoskeleton systems, and oxidative stress (Figure
S2). Statistically significant test results for genes or proteins
enriched in pathways performed with DAVID software were
obtained for several pathways related to changes in both the
microarray and proteomics experiments (Figure S3). These
pathways include glycolysis, oxidative phosphorylation,
hormonal pathways and cytoskeletal remodeling.
Biological relevance of pathways associated with METH
syndrome
The pathways that we observed in our transcriptomic and
proteomic analyses are consistent with the known effects of METH
on biological systems, including proteases, detoxification enzymes,
oxidative stress and iron homeostasis (See Text S1). However,
because we analyzed whole-organisms, as compared to previous
studies on brain tissue [3,4,5], we observed proteins that had not
been previously associated with METH-induced responses,
including certain proteins involved in the electron transport chain,
muscle formation/homeostasis, and spermatogenesis.
Mitochondrial electron transport chain (ETC)
METH has been previously shown to affect the mitochondrial
electron transport chain (ETC) [21]. We observed changes in the
abundance of proteins associated with the ETC, corroborating the
work of others who have observed that METH inhibits the ETC in
mice and rats [9,22]; Burrows and co-workers observed the
inhibition of cytochrome oxidase activity [9] (complex IV of the
ETC) in rat brains after METH treatment, and Brown et al. [23]
observed that succinate dehydrogenase (complex II of the ETC)
was inhibited by METH in the striatum of rats. We observed
changes in the prevalence of multiple proteins in the oxidative
phosphorylation pathway beyond complex II and IV (Figure S3),
including those associated with complex I (phosphoglycerate
mutase [pglym78] and NADH dehydrogenase [ubiquinone] 1
alpha subcomplex subunit 10 [ND42)]), complex III (CG3815 with
ubiquinol-cytochrome-c reductase activity), and complex V (ATP
synthase subunit alpha [also known as bellwether in Drosophila]) of
the ETC (Figure 1). Alaux et al. observed that aggression in bees is
associated with reduced enzyme activity for complexes I (NADH
dehydrogenase), IV (cytochrome c oxidase), and V (ATP synthase)
[24] (Table S2). Whether METH-induced aggressive behavior is
associated with the oxidative phosphorylation pathway has not
been determined.
Proteins related to muscle and heart disease. METH
causes muscle loss [25,26] and heart failure in humans [27],
however, little is known about the molecular mechanisms by which
METH causes this effect. In Drosophila, we observed that the
concentrations of numerous muscle-associated proteins changed in
response to METH exposure. For example, dynein heavy chain
and troponin c decreased 6- and 2-fold, respectively, and
tropomyosin protein levels increased 10-fold (Table S2).
Additionally, we observed that three MyHC peptides increased
approximately 10-fold (Table S2) and two other MyHC peptides
decreased 8-fold with METH treatment, suggesting that METH
likely disrupts normal muscle physiology in Drosophila. This is
supported by the observation that changes in the relative mRNA
expression of alpha - and beta-myosin heavy chain (MyHC) are
associated with chronic heart failure in humans [28].
Spermatogenesis- and ejaculation-related proteins. METH
causes sexual dysfunction in mammals, inhibiting sperm motility
[29], and amphetamines, which are structurally similar to METH,
retard ejaculation in humans [30]. Although METH is known to
have negative effects on male fertility [29] little is known regarding
the molecular impacts of METH on spermatogenesis. In our
study, we detected seven METH-responsive genes and proteins
that are associated with reproductive functions in males (Tables S2
& S3), some of which are evolutionarily conserved in humans.
The transcript of CG11893, which was up-regulated in METH-
treated flies, is associated with the Androcam gene; this gene encodes
a protein abundantly expressed in the cones of the testes in
Drosophila [31]. The C-domain of Androcam binds calcium and has
67% homology with a mammalian calmodulin [32] protein that
has testes-specific calcium signaling functions [31]. CG11893,
which is associated with poe, has protein-binding functions
(UniProtKB).
The protein CG32542, which is over-expressed in METH-
treated flies, interacts with ocn (iHOP- http://www.ihop-net.org/)
[33], a testes-specific gene [34]. The protein CG3815 was under-
expressed in METH-treated flies and interacts with sneaky, a testes-
expressed gene involved in sperm exocytosis in Drosophila [35].
Fertilization typically involves membrane fusion between sperm
and eggs. In Drosophila, however, sperm enter eggs with
membranes intact, and the membranes are broken down in the
egg; only then are the sperm activated. Mutations in sneaky can
impair this process, resulting in male sterility due to impaired
sperm plasma membrane breakdown [35]. Sneaky-like genes have
also been detected in humans [35].
Tubulins also have an important function in spermatogenesis
[36]. We observed that the alpha-tubulin 84B protein, a
component of the spermatozoa cytoskeleton involved in spermatid
development [37], decreased in METH-treated flies. Two
mitochondrial proteins—porin, which decreased, and bellwether,
which increased—were identified in flies exposed to METH. Porin
is localized in the outer mitochondrial membrane of germ cells in
the testes and in the spermatozoa in Drosophila [38]. The
mitochondrial ATP synthase subunit alpha of complex V
(bellwether) is also involved in spermatogenesis and is associated
with male sterility [39]. In addition, the expression of the
predominant ejaculatory bulb protein (PEB-me), a component of
the mating plug in Drosophila [40,41], increased 10-fold in response
to METH treatment (Table S2). Moreover, the germ cell nuclear-
like factor (GCNF) was identified in METH-treated flies; this
potential transcription factor binding motif (TFBM) is associated
with germ cells (Figure S4, S5, S6, Text S1, Table S4 and Table
S5). GCNF targets several genes involved in sperm maturation.
Metabolomic profiling and dietary trehalose
Previous studies in mammals have shown that METH toxicity is
interrelated with metabolism in the brain and sugar levels in the
blood [3,4,5,42,43]. Thus, we also investigated changes in whole
organism sugar levels in Drosophila in response to METH. Using
gas chromatography/mass spectrometry (GC/MS), we observed
decreased trehalose levels in METH-exposed Drosophila
(p,0.0001; Figure S7). That trehalose acts as an antioxidant
[18,44], and thus is itself oxidized, could account for reduced
trehalose levels. Because trehalose is the major blood sugar in
insects, decreased levels of trehalose could also reflect either higher
metabolic rates resulting from a METH-induced increase in
physical activity or increased carbohydrate consumption resulting
from increased glycolysis.
We found that METH-treated flies fed a diet containing
trehalose or sucrose lived longer than flies treated only with
Insights into the Methamphetamine Syndrome
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sorbitol, a sugar alcohol that is not well metabolized by Drosophila
[45], had no impact on METH toxicity. These results suggest that
METH-toxicity is interrelated with carbohydrate metabolism,
corroborating previous findings where it has also been observed
that supplementation with cofactors of energy metabolism
attenuates the toxicity of METH [8,46]. Interestingly, human
METH addicts often imbibe large amounts of sugary soft drinks
[47]; such dietary studies in Drosophila lead us to question whether
sugar intake in humans helps to alleviate the toxic effects of
METH.
Oxidative stress
We observed multiple genes and proteins associated with an
oxidative stress in METH-treated Drosophila; METH also induces
oxidative stress in mammals [6]. Oxidative stress has been linked
to many pathways, including alcohol dehydrogenase (ADH)
activity [48], actin reorganization [49], and the inhibition of
hexokinase activity in rabbit erythrocytes [50]. Aconitase also
helps to regulate resistance to oxidative stress and cell death in two
plant species, Arabidopsis thaliana and Nicotiana benthamiana [51].
Consistent with the hypothesis that the METH-treated flies are
experiencing oxidative stress, we observed decreases in alcohol
dehydrogenase (ADH) and aconitase, as well as increases in
hexokinase and actin (Table S2).
Oxidative stress also causes thiol oxidation in the glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) of Staphylococcus aureus
[52] and increases GAPDH transcript levels in rabbit aortas [53].
Perhaps because of the oxidative stress involved in exposure to
METH, we observed a 10-fold increase in GAPDH in the treated
flies (Table S2). GAPDH belongs to an evolutionarily conserved
protein family, the aldehyde dehydrogenases; these play a key role
in stress responses, including oxidative stress [54,55].
Our data also suggest that METH induces multiple pathways
associated with the generation of reactive oxygen species (ROS)
(Figure 2). Flies challenged with METH differentially expressed
multiple genes and exhibited changed protein levels associated
with the mitochondrial ETC, potentially leading to ROS
formation. High levels of P450s, which we observed in METH-
treated Drosophila, in some cases can also lead to the generation of
ROS during detoxification and catabolism, which can cause
downstream ROS formation. For example, the degradation of the
endoplasmic reticulum [56], the main Ca
2+ storage areas of the
cell, disrupts Ca
2+ homeostasis [57]. Dysregulation of Ca
2+
homeostasis can lead to cell death, especially under conditions of
oxidative stress, because high levels of cytoplasmic Ca
2+ can cause
the formation of nonspecific pores, known as permeability
transition pores, in the inner mitochondrial membrane. These
pores may cause the mitochondria to swell massively, depolarize,
and generate ROS, leading to cell death [58]. Additionally, the
tumor suppressor p53 protein is induced by ROS, leading to
apoptosis following treatment with METH [59,60,61].
ROS react with and cause damage to cellular macromolecules,
including DNA and membrane phospholipids. For example, ROS
can chemically modify and fragment DNA [62], potentially
leading to genetic mutations. Helicases play a central role in
repairing DNA damage caused by UV-light and ROS. These
proteins also reverse the DNA damage associated with replication
errors and thus help maintain genomic stability. Our observation
that one helicase was down-regulated (Table S2) is consistent with
the hypothesis that METH causes oxidative DNA damage [63].
For membrane phospholipids, ROS cause lipid peroxidation, a
process that may result in the degradation of cellular and
mitochondrial membranes. The resulting change in mitochondrial
membrane permeability triggers a signaling cascade that causes
the release of cytochrome c into the cytoplasm, triggering the
downstream caspase-dependent apoptosis [64]. Mitochondrial
degradation might contribute to higher levels of free Ca
2+ that
can in turn activate phospholipase A, promoting the hydrolysis of
membrane phospholipids, which further disrupts the cellular
compartmentalization of Ca
2+. Furthermore, P450 enzyme
systems, which were up-regulated in METH-exposed Drosophila,
in some cases modulate Ca
2+ channels that in turn trigger fluxes of
Ca
2+ [65]; these further increase levels of intracellular free Ca
2+.
An imbalance in Ca
2+ homeostasis due to oxidative stress is also an
important factor in heart disease [66].
Iron also plays a role in responses to oxidative stress. Free iron,
through the Fenton reaction, can produce harmful free radicals
from hydrogen peroxide [67]. Ferritin, a major regulator of iron
homeostasis [68], chelates iron and prevents the Fenton reaction.
Therefore, it is reasonable to hypothesize that the down-regulation
of ferritin that we observed with METH-exposure could enhance
the generation of ROS.
Integrating the effects of METH on cellular pathways
METH-treated Drosophila differentially expressed multiple
genes, proteins, and pathways associated with both hypoxia and
the Warburg effect (aerobic glycolysis) [16,17] (Figure 3). In the
mammalian liver, pyruvate kinase is positioned at a key branch-
point in glucose metabolism, and a high expression level of this
protein is correlated with the aerobic status of the cell [69]. This
enzyme was down-regulated in the METH-treated flies, suggesting
that METH either induces an anaerobic response or a Warburg-
like effect [70] or some third hitherto unknown process.
The heat shock protein 60 (Hsp60), primarily a mitochondrial
Hsp, is also an indicator of the aerobic status of the cell and is
involved in the apoptotic response [70,71]. Hsp60 is expressed at
high levels in normal cells, but hypoxia decreases its expression
and/or changes its cellular distribution [70], causing apoptosis.
Indeed, decreasing the level of Hsp60 in cardiac myocytes was
sufficient to cause apoptosis [71]. Hsp60 forms a macromolecular
complex with the pro-apoptotic protein BAX, which blocks the
ability of BAX to translocate to the mitochondria and to promote
apoptosis in vivo [70]. The reduced expression of the Hsp60 protein
in METH-treated flies, which we observed, supports the idea that
METH induces hypoxia.
Levels of the mitochondrial ATP synthase, bellwether, increased
with METH exposure. The over-expression of the subunits of the
catalytic core of the mitochondrial F(0)–F(1) ATP synthase
complex, including the alpha-subunit, are correlated with
Table 1. The lethal time 50 (LT50) and 95% confidence
interval (C.I.) of Drosophila melanogaster fed on
methamphetamine (METH), and different sugars (including
trehalose, sucrose, and sorbitol) plus METH.
Treatment LT50 (h) 95% C. I. (h) P value*
METH 0.6% 50.40 45.19–55.58 –
Trehalose 0.189M+METH 0.6% 91.99 80.31–112.04 ,0.01
Sucrose 0.189M+METH 0.6% 71.88 67.34–77.03 ,0.05
Sorbitol 0.189M+METH 0.6% 62.68 56.74–69.01 N.S.
*Comparisons were between the LT50s of the given sugar plus METH treatment
versus the METH only treatment. N.S. stands for not significant. The LT50sa n d
treatment comparisons were performed using SAS (Cary, NC).
doi:10.1371/journal.pone.0018215.t001
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transient increase in intracellular ATP levels, which is necessary
for apoptosis [72]; pharmacologically inhibiting ATP synthase
blocks apoptosis. Apoptosis is induced in response to a specific
signal that indicates an imbalance between aerobic and anaerobic
ATP biosynthesis [69].
Several oncogenes have been implicated in the Warburg effect,
including the serine-threonine kinases (AKT) that enhance glucose
uptake and aerobic glycolysis in cancer cells [73] and are able to
do so independently of hypoxia-inducible factor (HIF-1); the levels
of two AKT proteins significantly changed in the METH-treated
flies. AKT mobilizes glucose transporters to the cell surface to
enhance glucose uptake and activates hexokinase (HK) [73], a
protein that was over-expressed in the METH-treated flies.
Elstrom and co-workers reported that through these effects,
AKT is able to enhance glycolytic flux without affecting
mitochondrial oxidative phosphorylation, thereby presumably
contributing to the Warburg effect [73]. Moreover, the AKT
and phosphatidylinositol triphosphate kinase (PI3K) protein levels
were up-regulated in METH-treated flies. The PI3K-AKT
signaling pathway promotes cell growth, increases glucose uptake,
influences cell cycle progression, and prevents apoptosis through
multiple mechanisms [73].
The transcription factor c-Myc, a known oncogene, regulates
the cell cycle, differentiation, apoptosis, metabolism, and cellular
responses to oxidative stress. Typically, the expression of c-Myc is
tightly regulated by multiple transcriptional activators and
repressors. In METH-treated Drosophila, however, multiple genes
that regulate c-Myc were differentially expressed. For instance,
YY1 transcription factor, which has previously been associated
molecular responses to oxidative stress and heart disease [74,75],
activates the transcription of Notch 1 transcription factor (N1IC)
[76]. Subsequently, the N1IC-YY1 complex binds to the major
promoter of the c-Myc gene and activates its expression [76]. In
addition, enolase, which was up-regulated in METH-treated flies,
and promoter binding protein 1 (MBP-1), which results from an
alternative translation initiation codon of the enolase gene, are
transcriptional repressors of c-Myc [77]. The simultaneous up-
regulation of transcriptional activators and repressors suggests that
METH disrupts the fine control of c-Myc.
Figure 2. Changes in energy metabolism and apoptosis in response to METH treatment. In METH metabolic syndrome, key glycolytic
enzymes [i.e., HK (hexokinase), ALD (aldolase), GAPDH (glyceraldehydes 3-phosphate dehydrogenase), and ENO (enolase)] are up-regulated (upward-
pointing red arrows), presumably leading to higher glycolytic flux. PYK (pyruvate kinase), however, was down-regulated (downward-pointing red
arrow), diverting pyruvate away from oxidative respiration towards fermentation to lactic acid. Mitochondrial degradation (see Figure 3 for detailed
discussion) and dysregulation of the electron transport chain (see Figure 1) may also contribute to decreased oxidative respiration. Hsp60 binds to
BAX, preventing apoptosis. Thus, the down-regulation of Hsp60 observed with METH exposure may potentially increase free BAX, leading to
apoptosis. Multiple genes known to transcriptionally regulate glycolysis and/or apoptosis were differentially regulated during METH exposure,
including (i) AKT and PI3K, which were up-regulated, enhancing glycolysis and carbohydrate transport across the cellular membrane, and (ii) iron
chelators (Fe-Ch), which were down-regulated and are known to interact with HF1a (genes not detected experimentally, indicated by dashed lines). In
addition, ENO1 and YY1, which suppress and activate, respectively, the transcription of c-Myc, were both up-regulated, suggesting a loss of fine
control over c-Myc. c-Myc in turn regulates the transcription of many other genes including those involved in apoptosis and glycolysis.
doi:10.1371/journal.pone.0018215.g002
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activation of aerobic glycolysis in human cancers. Numerous
METH-responsive glycolytic genes and proteins detected in our
microarray and proteomic analysis are known to interact with c-
Myc (Figure S3). For example, c-Myc activates many glycolytic
genes, including hexokinase (HK) and enolase [78,79], both of
which were over-expressed in METH-treated flies.
Increased glycolytic activity requires increased glucose uptake
via glucose transporter proteins and the increased expression of
glycolytic enzymes. METH treatment induced changes in the flies’
expression of glucose transporters, adolase (Ald), and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) (Table S2). Ald and
GAPDH are associated with the production or elimination of
glyceraldehyde-3-phosphate in the process of glycolysis or
gluconeogenesis, and are differentially expressed under many
physiological conditions, such as cancer, hypoxia, and apoptosis
[80,81].
The Warburg effect is also associated with other apoptotic
pathways, including one that is induced by voltage-dependent
anion channels called porins [82]. Porins are located in the outer
mitochondrial membrane and have been widely implicated in the
initiation of the mitochondria-mediated intrinsic pathway of
apoptosis. Furthermore, porins have been characterized as an
important component in the distribution of mitochondrial
membrane cholesterol, which in turn is associated with aerobic
glycolysis [82]. Importantly, porin is a binding partner for HK, a
protein associated with the Warburg effect [82,83]. The increased
affinity of porin to HK increases cellular access to ATP, which
increases use of the glycolytic pathway. Therefore, the direct
binding of HK to porins and the involvement of porins in cell
death suggest that interactions between HK and porin are a
component of apoptosis regulation by HK [83]. In METH treated
flies, porins were under-expressed and HK protein increased more
than 10-fold. It is possible that alterations in the HK-porin
relationship influence the apoptotic pathway. This prediction is
supported by a recent report that the over-expression of HK in
human cells suppressed cytochrome c release and apoptotic cell
death [83]. In addition, a single mutation in porin decreased HK
binding, diminishing the protection that HK offers against cell
death. Alternatively, Chiara and co-authors suggested that HK
detachment (independent of porins) from mitochondria induces
the PTPs that cause mitochondrial degradation and apoptosis
Figure 3. METH exposure may promote oxidative stress through multiple mechanisms. First, cytochrome P450s are up-regulated
(upward-pointing red arrow) to potentially detoxify METH but in some cases also produce reactive oxygen species (ROS) byproducts. Second, METH, a
weak base, is known to alkalinize dopamine (DA)-containing vesicles, promoting DA release into the cytosol. Cytosolic DA is rapidly degraded,
resulting in ROS byproducts. Third, iron chelators are down-regulated (downward-pointed red arrow), potentially increasing the concentration of free
iron, a known source of ROS. Fourth, degradation of the mitochondria, potentially resulting from (i) the ability of high cytosolic Ca
2+ to promote the
formation of permeability transition pores (PTP), (ii) increased membrane hydrolysis by Ca
2+-dependent phospholipase A2 (PLA2) in the presence of
increased Ca
2+, (iii) the direct effects of ROS on mitochondrial integrity, and (iv) the potential effects of altered HK/porin ratio - HK detachment from
mitochondria on PTP formation. This may cause the mitochondria to uncouple and result in ROS production. The cellular targets of oxidative stress,
indicated by orange arrows, include membrane phospholipids; p53, a gene that regulates apoptosis; and DNA.
doi:10.1371/journal.pone.0018215.g003
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over-expression of HK corresponds to an anti-apoptotic defense
mechanism used by malignant cells [85].
Both enolase (which synthesizes phosphoenol pyruvate) and
calcium ion homeostasis are also involved in apoptosis. Some
cancers, such as neuroblastoma, have an associated genomic
deletion that corresponds to the enolase gene (ENO1). When a
functional copy of enolase is transfected to this type of cancer cell,
it causes apoptosis [86]. Additionally, METH-treated flies up-
regulated enolase 10-fold. Calcium also has an important role in
signaling pathways associated with cell death and drug resistance
[87]. The cytosolic Ca
2+ concentration is controlled by interac-
tions among transporters, pumps, ion channels, and binding
proteins. Consistent with these observations, METH treatment
affected the expression of several calcium-binding proteins (Table
S2). Drosophila possessing a mutant Giiispla2 gene (Table S6),
which encodes a Ca
2+ binding protein, was more susceptible than
the w
1118 control to METH, suggesting that the disruption of Ca
2+
homeostasis affects apoptosis. Alternatively, increased susceptibil-
ity of the Giiispla2 mutants might be related to altered arachidonic
acid metabolism (Table S1).
Iron chelators also activate a hypoxia stress-response pathway.
We found that the METH syndrome decreases the expression of
ferritin and aconitase (Table S2). Iron chelators induce the
expression of hypoxia-inducible factor-1 (HIF-1) and glycolytic
enzymes [16,88]. These studies highlight the diversity of cellular
responses to iron chelators and suggest that these multifunctional
antiapoptotic agents may enhance survival by suppressing ROS
generation as well as by inducing glycolytic enzymes, such as
aldolase and enolase, and glucose channels. Changes in the
expression of these genes are observed in the METH syndrome
(Table S2 & Table 1).
In summary, our observations indicate that METH impacts
pathways associated with hypoxia and/or the Warburg effect,
pathways in which cellular energy is predominantly produced by
glycolysis rather than by oxidative respiration. These results are
consistent with the fact that METH use is associated with the
formation of lactic acid (Figure 2) [8]; lactate dehydrogenase
mRNA was over-transcribed 1.8-fold in METH-treated flies
(p,0.01). Further work is required to validate the role of these
pathways in response to METH. However, an approach based on
systems biology, validated by mutant analysis or feeding studies or
both, has the potential to accelerate the discovery of the molecular
effects of drugs and potential dietary factors that can alleviate the
effects of drugs. Additionally, two mutants for two separate genes
with previously unknown function (CG14280 and CG7796) were
more susceptible to METH (as compared to the non-mutant
control flies), raising the possibility that systems biology in
combination with targeted mutant analysis could be useful for
elucidating other unknown aspects of METH toxicity (Table S6).
Materials and Methods
Drosophila melanogaster stock
The w
1118 strain was obtained from Dr. Misha Ludwig
(University of Chicago) and reared on the Formula 24H Drosophila
diet (Carolina Biological Supply, Burlington, NC) at 22–23uC and
60–70% humidity.
METH bioassays
For microarrays and proteomic and metabolomic experiments,
virgin male flies were collected during the sixth to seventh hours
following eclosion from the pupae [89] and cultured for 5 days.
Twenty of these flies were then placed on a standard fly diet
(control) or a diet supplemented with 0.6% (w/v) METH (Sigma,
M8750, St. Louis, MO) for 24 h. Three biological replicates were
performed for each experiment (for a total of six samples). At the
end of the 24 h feeding period, the 20 flies were collected, flash-
frozen in liquid nitrogen, and stored at 280uC. These samples
were subsequently used in the DNA oligoarray experiments,
proteomic or metabolite analyses.
For toxicology experiments of sugar feeding treatments, virgin
male flies were collected as aforementioned, and cultured for 5
days. Nine of these flies were placed on one of following diets: 1)
0.6% (w/v) METH (methamphetamines), 2) 0.6% METH+5%
(0.189M) trehalose (Sigma, T9449, St. Louis, MO), 3) 0.6%
METH+5% (0.189M) sucrose (Sigma, 84097, St. Louis, MO), and
4) 0.6% METH+0.189M sorbitol (Sigma, W302902, St. Louis,
MO). Three biological replicates were performed for each
treatment.
For toxicology experiments of mutant flies, 3–5-day-old male
flies were collected to determine the lethal time 50 (LT50). Five of
these flies were placed on either a standard fly diet (control) or a
diet supplemented with 0.6% (w/v) METH. Six biological
replicates were performed for each mutant. Mutant flies were
ordered from Bloomington Drosophila Stock Center at Indiana
University.
Microarray experiment
Total RNA was extracted using Trizol reagent for each
replicate (Invitrogen Life Technologies, Carlsbad, CA). Three
replicates each were used for control and METH-treated flies.
DNA contamination was removed by DNaseI set (Qiagen Inc.,
Valencia, CA) followed by another step of Trizol extraction to
remove DNase. Affymetrix oligoarray experiments were per-
formed as described in Pedra et al. [90]. Amplified cRNA was
hybridized to Affymetrix Drosophila Genome 2.0 Arrays (Affyme-
trix, Santa Clara, CA); this array allows for the potential analysis of
over 18,500 different Drosophila transcripts. Gene-chip-operating
software (GCOS 1.4) was used to quantify the images. Microarray
data were deposited in the Gene Expression Omnibus (GEO)
database with accession number GSE16198.
Quantitative real time PCR (qRT-PCR)
cDNA was synthesized using 1 mg of total RNA with iScript
cDNA kit (Bio-Rad, Hercules, CA) in a 20 ml reaction. Primers
(Table S7) were designed by primer3 online and Genscript Real-
Time PCR Primer Design (http://fokker.wi.mit.edu/primer3/
input.htm & https://www.genscript.com/ssl-bin/app/primer).
The 26 iQ SYBR Green Supermix was purchased from Bio-
Rad (Hercules, CA). qRT-PCRs were performed on an iCycler
Thermal Cycler with an annealing temperature of 60uC and 30
cycles. Each cDNA sample has triplicates. The statistical analyses
of the relative gene expression level were performed using the SAS
TTEST (SAS Institute Inc., Cary, NC). AFFX-Dros-ACTIN_M_r
was used as the reference gene, and the significance analysis of the
microarray (SAM) and transcriptional analyses of 21 genes were
performed on it.
Metabolomic and GC/MS procedure
For metabolite extraction, each sample was removed from the
freezer and 200 mL of 100% ethanol was added to each tube. A
sterile plastic pellet pestle was used to grind each sample for
3 minutes. The samples were then placed onto a heating block set
to 80uC. After 10 minutes, 400 mL of methanol/water (50:50 v/v)
mixture was added and vortexed for 30 minutes at room
temperature. Once the extraction was complete, the tubes were
centrifuged at 13,000 g for 10 minutes. The supernatant was
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device at 43uC for 3 hours. The samples were derivatized with
20 mL of O-Methylhydroxylamine-HCl solution (20 mg/mL
anhydrous pyridine) by heating them to 60uC for 30 minutes.
Subsequently, 30 mL of MSTFA labeling reagent was added to
each tube and incubated at 60uC for one hour. After the heating
process, each sample was allowed to cool to room temperature and
then transferred to a glass autosampler vial.
The GC-MS instruments used were the Pegasus 4D GCxGC-
TOFMS from Leco Corp (St. Joseph, MI), an Agilent 6890N GC,
and an Agilent 7683B Series autosampler. The first dimension
column was a HP-5MS phase, 30 m length, 0.250 mm I.D.,
0.25 um film. The second dimension column was a DB-17 phase,
1 m length, 0.100 mm I.D., 0.10 um film. Both columns were
from Agilent. A 3 mL injection was made for each sample using
helium as a carrier gas at a flow rate of 1 mL/minute.
The front inlet split was set to 20 and the inlet temperature was
280uC. The temperature gradient was as follows: 50uC for
0.20 minutes, ramped 10uC/min to 250uC and held for
10 minutes, ramped 25uC/min to 300uC and held for 5 minutes.
The second dimension temperature profile was exactly the same,
only +20uC. The transfer line between GC and MS was set to
250uC. The MS had a solvent delay of 150 seconds. Data were
collected from 30–1000 m/z with an acquisition rate of 100
spectra/second. The detector voltage was 1700 and electron
energy was 270 V. The ion source was set to 200uC. All data were
processed using Leco ChromaTOF software (Version 3.32). Area
and height calculations were based on the 73 ion. Standard curves
for the trehalose metabolite were generated, using an equimolar
mixture of standards at 5 concentrations (0.5, 0.25, 0.05, 0.025,
and 0.005 mmols).
Statistical analyses for FDR in microarrays, cellular
metabolomics, and toxicity
The oligoarray data were transformed by log base 2 and
normalized by AFFX-Dros-ACTIN_M_r, and then analyzed
using the significance analysis of microarrays (SAM) [91]. A list
of genes with associated q-values [92] was generated using defined
false discovery rates (FDRs) (we used 5% and 10%). The q-value
gives the minimum value at which that gene will be considered
significant. The cellular metabolomics dataset was analyzed by
absolute quantification: a separate standard curve was completed
for each metabolite, which allowed us to regress the density (area
under the curve) to a known concentration of the metabolite. The
standards curve was estimated by regressing density on concen-
tration to obtain the linear coefficient. This coefficient, estimated
independently for each metabolite, was then used to convert
observed densities in the experimental data to quantities (mmoles)
of the cellular metabolites.
The quantified data were then transformed by logs and
analyzed by SAS Proc Mixed as a split plot with treatments;
biological replicates within treatments were analyzed as whole plot
effects, and cellular metabolites and cellular metabolite6treatment
interactions were analyzed as split plot effects since all cellular
metabolites sampled were correlated within a replicate. Replicates
within treatments were the error term used to test treatment
effects, while residue was used to test cellular metabolite6treat-
ment interactions. The cellular metabolite6treatment interaction
was the term of greatest interest, as it indicated which cellular
metabolites were being affected by treatments. If the interaction
was significant, means by cellular metabolite were compared for
treatment effects by comparisons using single degrees of freedom.
For the toxicology experiments involving sugar feeding (Table
S7) and mutant screening (Table S8), data were analyzed using the
PROBIT procedure of SAS. The PROBIT procedure computes
maximum likelihood estimates of the parameters of the probit
equation using a modified Newton-Raphson algorithm. When the
response Y is binary, with values 0 and 1, the probit equation is
p=Pr(Y=0)=C+(12C)F(x’B), where B is a vector of parameter
estimates, F is a cumulative distribution function (normal, logistic,
or extreme value), x is a vector of explanatory variables, p is the
probability of a response, C is the natural (threshold) response rate.
The PROBIT procedure fits a common slope cumulative model,
which is a parallel-line regression model based on the cumulative
probabilities of the response categories rather than on their
individual probabilities. The cumulative model has the form Pr
(Y,i|x)=F(a+x’B). In our case we used the cumulative normal
distribution for F, and x is log(time). The LT50 is estimated as
LT50=2a/B because when Pr (Y,i|x)=.5, the x corresponds to
the center of the standardized normal distribution, or when
a+x’B=0. We estimated the LT50 with at least 5 independent data
sets for each mutant. The error variance for the LT50 was
estimated empirically as the variation among replicate estimates of
the LT50 for that mutant and pooled across mutants. The
combined data set was then analyzed by Proc GLM with mutants
as treatments. Because there were different numbers of replicates
per treatment, least squares means were computed for each
mutant with corresponding standard error of the mean. Means
were separated using planned comparison to the control only to
control experiment wise error rate.
DNA transcription factor binding motif analyses
The method of analysis was as described by Li et al. [93].
Transcription factor binding motifs (TFBMs) may regulate gene
transcription in response to METH. Thus, we assessed the
potential TFBMs of the 18 up-regulated genes (5% FDR) and 5
down-regulated genes (10% FDR) in response to METH
treatment. The promoter regions near the genes were analyzed.
The analysis included the 800 bp upstream and 200 bp down-
stream region from the transcription start site (TSS) of the gene.
The distance indicates a dissimilarity measurement between any
pair of position weight matrices (PWMs), so the smaller the value,
the more similarity between the PWM and the mammalian
TFBM. Distances of 0.1 or less indicated that the D. melanogaster
TFBM was very similar to the respective mammalian one.
Proteomic analyses
Sample preparation. Proteins were denatured and reduced
with 8 M Urea (Fischer Scientific) and 10 mM dithiothreitol
(DTT) (Fischer Scientific) for 1.5 hours at 37uC followed by
further reduction and alkylation with 0.5% Triethylphosphine
(TEP), 2% 2-Iodoethanol and 97.5% Acetonitrile for 1.5 hours at
37uC. Proteins were trypsin digested at a ratio of 1:50 (w/w
trypsin/protein) overnight at 37uC. The supernatant was removed
and applied to a C18 microspin column (Nest Group,
Southborough, MA) for buffer exchange and desalting. The
resulting peptides were dried down and resuspended in 100 ml
0.01% TFA in water.
NanoLC-Chip-MS. The peptides (0.5 mg) were concentrated
on the on-chip 300SB-C18 enrichment column at a flow rate of
4 ml/min for 5 minutes and separated with the on-chip C-18
reversed phase ZORBAX 300SB-C18 (0.75 mm6150 mm;
Agilent) analytical column coupled to the electrospray ionization
(ESI) source of the ion trap mass spectrometer (1100 Series LC
equipped with HPLC chip interface, Agilent, XCT Plus, Agilent).
A 55 min linear gradient from 5%–35% buffer B (100%
acetonitrile, 0.01% TFA) at a rate of 300 nl/min, followed by a
10 minute gradient from 35%–100% buffer B was used to elute
Insights into the Methamphetamine Syndrome
PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18215the column. After elution of the column, an isocratic flow (5%
buffer B) at 300 nl/min was used for equilibration.
NanoLC-Chip-MS/MS and targeted MS/MS. Peptides
were separated on a nanoLC-Chip system (1100 Series LC
equipped with HPLC chip interface, Agilent, Santa Clara, CA)
using the same platform as described above. Automated MS/MS
spectra were acquired during the run in the data-dependent
acquisition mode with the selection of the three most abundant
precursor ions.
Data mining. The raw data files were converted into
mzXML format using Bruker’s CompassXport program and
then analyzed using the ‘‘Proteomics Discovery Pipeline’’ (PDP). A
chi-square statistical analysis was used to determine the significant
peaks that were present in one group (e.g. treated) but not in the
other (untreated). Peaks present in both sample groups but with
significantly different intensities were evaluated by the standard
two-sample t-test. The peptide peaks were ranked by their p-values
and by their fold-change. The cut-off values were set at a 5% false
discovery rate (p-value,0.05) and 2-fold or greater change in
protein quantity. All peaks with p-values less than the cut-off were
selected as differentially expressed peptides between the treated
and untreated groups.
Protein identification. NanoLC-Chip-MS/MS results were
analyzed using Spectrum Mill A.03.02.060 software (Agilent
Technologies) and searches were performed against the National
Institutes of Health National Center for Biotechnology
Information (NCBI) protein database specifically for Drosophila.
The parameters of the search were as follows: no more than two
tryptic miscleavages allowed, cysteine searched as iodoethanol,
1.0 Da peptide mass tolerance and 0.7 Da MS/MS mass
tolerance. Only peptides with a score of 6 or higher and %SPI
of 60 or higher were considered true positives.
Overlap of MS and MS/MS data. A significant peak list, a
treated peptide/protein list and an untreated peptide/protein list
were generated from MS and MS/MS data, and the lists were
combined. The MS and MS/MS raw data were compared to
guarantee that the molecular information [m/z (+/20.7 Da),
retention time (+/20.5 min), charge state] and chromatographic
patterns were the same.
Gene ontology and KEGG analyses. The GeneChip
Drosophila Genome 2.0 Array contains probe sets interrogating
18,952 genes from Drosophila, 14,705 of which used in the design of
this array can be found in Flybase (http://flybase.org/). A
combination of fold-change and test p-value methods are used to
identify differentially expressed genes between control and METH
treatments. For this method, genes were ordered on p-values
derived from the t-statistic and reported only when a fold-change
was greater than the given threshold–a practice commonly used in
cDNA microarray data analysis [94]. Cutoff was set by a p
value#0.005 and the absolute fold-change $1.5 to choose
differentially expressed genes.
Gene ontology categorization and pathway comparison were
performed using the following databases: gene ontology (GO)
system (http://www.geneontology.org) [95] and Kyoto Encyclo-
pedia of Genes and Genomes (http://www.genome.ad.jp/kegg/)
[96]. Fisher’s exact test was used to test the statistical significance
of associations between the gene list and expression changes and
function set [97]. Significance levels for pathway comparisons
were set by hit number .2, allowing any assumptions about the
shape of sampling distribution of population to be avoided.
Network analyses. Differentially expressed transcripts and
proteins identified in this study were compared with known
networks in MetaCore integrated knowledge database using
statistical tests and scoring for network relevance to the dataset,
functional processes, cellular pathways and transcription factors of
GeneGo software (http://www.genego.com/metacore.php) and
DAVID. MetaCore
TM is based on a proprietary manually curated
database of human protein-protein, protein-DNA and protein
compound interactions, metabolic and signaling pathways for
human, mouse and rat, supported by proprietary ontologies and
controlled vocabulary. The most highly significant pathways are
summarized in Figure S2 and S3.
Supporting Information
Figure S1 Human gene orthologs of proteins in Dro-
sophila melanogaster associated with the METH re-
sponse. Drosophila genes and their respective human gene
orthologs were compared using David annotation software. The
genes found to have the same function in Drosophila and humans
were used to create the pie chart. The genes (Entrez_GeneID)
observed for each of the pathways are: glycolysis (31532, 33351,
33824, 35728, 42185, 42620, and 43447), biotin metabolism
(31551, 32095), steroid metabolism (53507 and 53511), oxidative
phosphorylation (42591, 43829, 37617, 42291, and 41550),
pyruvate metabolism (42620 and 42185), lipid metabolism
(33824 and 33839), amino acid metabolism (41561), apoptosis
and survival (35748), citrate cycle (42185), and starch and sucrose
metabolism (53507 and 326264).
(TIF)
Figure S2 Regulatory process maps based on proteomic
and transcriptomic data. Statistically significant regulatory
process maps (networks) using genomic and proteomic data from
Drosophila melanogaster treated with METH. Microarray and protein
chip data are shown in red and blue, respectively. The networks
maps were identified using the MetaCore integrated knowledge
database.
(TIF)
Figure S3 Regulatory metabolic maps based on proteo-
mic and transcriptomic data. Statistically significant meta-
bolic maps (networks) in Drosophila melanogaster associated METH
treatment, based on proteomic and transcriptomic data. Micro-
array and protein chip data are shown in red and blue,
respectively. Common pathways are given in green. The network
maps were identified using the MetaCore integrated knowledge
database.
(TIF)
Figure S4 Transcriptional factor binding motifs
(TFBMs) impacted by METH exposure. (A) TFBMs
detected from 17 of up-regulated genes with ,5% FDR. (B)
TFBMs detected from 5 of down-regulated genes with ,10%
FDR. Sequence logo was generated using the WEBLOGO
program.
(TIF)
Figure S5 Transcriptional factor binding motifs
(TFBMs) associated with over-transcribed genes. Over-
transcribed transcripts by methamphetamine in Drosophila melano-
gaster and the possible transcription factor binding motifs (TFBMs)
relative to the gene transcription start site (TSS). Different symbols
represent possible motifs. All transcripts are labeled with their
respective gene names.
(TIF)
Figure S6 Transcriptional factor binding motifs
(TFBMs) associated with under-transcribed genes. Un-
der-transcribed genes in Drosophila melanogaster in response to
treatment with methamphetamines and the possible transcription
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start site (TSS). Different symbols represent different possible
motifs. All transcripts are labeled with their respective gene names.
(TIF)
Figure S7 Trehalose levels of METH-fed insects moni-
tored by gas chromatography/mass spectrometry (GC/
MS). (A) GC/MS chromatogram of trehalose (the x-axis
represents the retention time); the dotted line represents the
control sample; the continuous line represents the METH-fed
sample at mass 73. (B) Log scale of the area of control vs. METH
with standard error bars (P,0.01). (C) Spectrum of trehalose. (D)
Structure of trehalose that had been silylated using N-Methyl-N-
trifluoroacetamide, Sialylation reagent (MSTFA) reagent.
(TIF)
Table S1 Pathways are ranked by the number of
proteins represented on protein chips and the number
of genes represented on microarray.
(XLS)
Table S2 Proteins observed over- and under-expressed
in methamphetamine-fed w1118 Drosophila melanoga-
ster adults.
(XLS)
Table S3 Drosophila melanogaster genes and human
gene orthologs were compared using David annotation
software.
(XLS)
Table S4 Potential transcription factor binding motifs
(TFBMs) observed from over- and under-transcribed
genes in w1118 Drosophila melanogaster adults treated
with methamphetamine.
(XLS)
Table S5 Genes that were differentially expressed in
the microarray experiments, based on FDR analysis, at
the q,10% levels in Drosophila melanogaster after 5-
day-old flies were exposed to a diet containing 0.6%
methamphetamine, as compared with flies reared on
control diet. Members of this gene set were used to predict
potential transcription factor binding motifs.
(XLS)
Table S6 The lethal time 50 (LT50) of Drosophila
mutants fed media containing methamphetamine.
(XLS)
Table S7 The reverse and forward primers used for the
qRT-PCR experiments.
(XLS)
Table S8 Genes that were differentially transcribed
(based on qRT–PCR) in w1118 Drosophila melanogaster
adults after 5-day-old virgin male flies were exposed to a
diet containing 0.6% methamphetamine, as compared
with flies reared on control diet.
(XLS)
Text S1 Supplemental Results.
(DOC)
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